Phreesia Wins Gold 2025 PM360 Pharma Choice Award in Partnership with the Colorectal Cancer Alliance 

A campaign designed by Phreesia that encourages patientprovider conversations around colorectal cancer screening received the industry’s top creative award 

ALL-REMOTE COMPANY/WILMINGTON, Del. — February 19, 2025 — Phreesia, a leader in patient activation, is proud to announce that it has received a Gold 2025 PM360 Pharma Choice award for a campaign to educate patients about colorectal cancer screening. The healthcare marketing industry trade publication PM360 recognizes the most innovative healthcare and life sciences campaigns through annual readers’ choice awards.   

Phreesia received a Gold award in the Unbranded category for its campaign developed in partnership with the Colorectal Cancer Alliance (Alliance), the leading nonprofit dedicated to ending colorectal cancer. The campaign drives patient awareness and promotes screening for early detection of colorectal cancer through a screening navigation tool at quiz.getscreened.org. The campaign was delivered to patients who were 45 years and older and who agreed to receive personalized messages at the point of care. Through this campaign, Phreesia and the Alliance aim to support timely screening, diagnosis and intervention for patients based on national guidelines. Patients learn about the types of colorectal cancer screening available and are encouraged to talk to their provider about the best screening option. Titled, “No ifs, and, or buts,” the campaign delivered more than 220,000 patient engagements between March and December 2024. 

“Educating patients about vital screenings is essential to support preventive care, and how that information is presented has a great deal to do with how much is understood, absorbed and acted upon,” said Phreesia’s Vice President of Life Sciences Content Strategy, Alexandra Beneville. “We’re honored to partner with leading organizations like the Colorectal Cancer Alliance to create effective messages, reach patients at key moments in their care journey and drive better health outcomes.” 

The Pharma Choice award winners are chosen by industry members. Entries are displayed online and readers vote on their favorites. A Gold, Silver and Bronze award is given to the top three vote earners in each of 14 categories, including: App, Consumer Website, DTC/DTP, Multichannel, Multicultural, Philanthropic, Professional Campaign (Print), Professional Website, Sales Aid, Self-Promotion/Corporate Campaign, Social Media, Unbranded, Variety and Video. 


About Phreesia

Phreesia is the trusted leader in patient activation, giving providers, life sciences companies and other organizations tools to help patients take a more active role in their care. Founded in 2005, Phreesia enabled approximately 150 million patient visits in 2023—more than 1 in 10 visits across the U.S.—scale that we believe allows us to make meaningful impact. Offering patient-driven digital solutions for intake, outreach, education and more, Phreesia enhances the patient experience, drives efficiency and improves healthcare outcomes. To learn more, visit phreesia.com.

About the Colorectal Cancer Alliance 

The Colorectal Cancer Alliance empowers a nation of passionate and determined allies to prevent, treat, and overcome colorectal cancer in their lives and communities. Founded in 1999 and headquartered in Washington, D.C., the Alliance advocates for prevention through initiatives like LEAD FROM BEHIND, magnifies support with BlueHQ, and accelerates research through Project Cure CRC. We are the largest national nonprofit dedicated to colorectal cancer, and we exist to end this disease in our lifetime. For more information, visit colorectalcancer.org.   

Media Contact: 

Nicole Gist 
nicole.gist@phreesia.com 
407-760-6274